Fig. 2From: Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIVHIV Protease drug resistance mutation frequency and levels of PI resistance. a Frequency of minor and major PI resistance mutations identified with NGS at different detection sensitivity thresholds in patients without experience of antiretroviral therapy (n = 96). b Levels of resistance to protease inhibitors calculated with the Stanford HIVdb program using the 20% threshold. ATV/r ritonavir-boosted atazanavir. LPV/r = ritonavir-boosted lopinavir. FPV/r ritonavir-boosted fosamprenavir. IDV/r = ritonavir-boosted indinavir. NFV nelfinavir. SQV/r ritonavir-boosted saquinavirBack to article page